Innova β2-glycoprotein I immunoglobulin G enzyme linked immunoassay test system (unsterilized) - Taiwan Registration 957fd686cf3a38e2574741cf413f1f26
Access comprehensive regulatory information for Innova β2-glycoprotein I immunoglobulin G enzyme linked immunoassay test system (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 957fd686cf3a38e2574741cf413f1f26 and manufactured by INOVA DIANOSTICS, INC.. The authorized representative in Taiwan is TRUGENE DIAGNOSTICS, INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
Semi-quantitative detection of β2 GPI IgG antibodies in human serum samples by immunoenzyme method (ELISA).
C Immunology and microbiology
C.5430 β-2-醣蛋白I免疫試驗系統
import
Dates and Status
Dec 01, 2005
Dec 01, 2025

